论文部分内容阅读
Dey公司的硫酸沙丁胺醇(albuterol sulfate)吸入溶液(AccuNeb),每3ml含沙丁胺醇1.25和0.63mg(相当于1.5和0.75mg硫酸沙丁胺醇)获FDA许可。这是第一个用于缓解2~12岁哮喘儿童支气管痉挛的预混、预定量、剂量减少
Dey’s albuterol sulfate inhalation solution (AccuNeb) is approved by the FDA for every 3 ml salbutamol 1.25 and 0.63 mg (equivalent to 1.5 and 0.75 mg salbutamol sulfate). This is the first premixed, scheduled, dose-reducing treatment for bronchospasm in children aged 2 to 12 years